logo

For the Inventor, By the Inventor

Toyama, Japan

Shuntaro Takano

USPTO Granted Patents = 27

Average Co-Inventor Count = 8.7

ph-index = 11

Forward Citations = 320(Granted Patents)


Location History:

  • Toyama, JA (1976 - 1978)
  • Toyama, JP (1978 - 1993)
  • Mitaka, JP (1999 - 2000)

Company Filing History:

goldMedal27 out of 159 
 
Toyama Chemical Co., Ltd.
 patents

Years Active: 1976-2000

Loading Chart...
27 patents (USPTO):Explore Patents
1. 6166068 - Immunomodulator, cell adhesion inhibitor, and agent for treating, and (2000-12-25),
2. 616606 - Immunomodulator, cell adhesion inhibitor, and agent for treating, and (2000-12-26),
3. 5922755 - Immunomodulator, cell adhesion inhibtor, and agent for treating, and (1999-07-13),
4. 5236950 - Process for hair growth (1993-08-17),
5. 4954518 - 4H-1-benzopyran-4-one derivative or its salt, process for producing the (1990-09-04),
6. 4851535 - Nicotinic acid derivatives (1989-07-25),
7. 4736026 - Novel process for producing a cephalosporin (1988-04-05),
8. 4704459 - Process for producing 1-substituted aryl-1,4-dihydro-4-oxonaphthyridine (1987-11-03),
9. 4656287 - Aminothiazole intermediate for a cephalosporin (1987-04-07),
10. 4410522 - Cephalosporins (1983-10-18),
11. 4395412 - 7.alpha.-Methoxycephalosporins (1983-07-26),
12. 4385178 - Process for producing 7-(substituted)amino-3-substituted thiomethyl (1983-05-24),
13. 4379152 - Cephalosporins (1983-04-05),
14. 4327097 - Novel penicillins (1982-04-27),
15. 4321265 - 7.alpha.-Methoxycephalosporins (1982-03-23),

Title: Shuntaro Takano: Pioneering Innovations in Immunomodulation

Introduction: Shuntaro Takano is a prominent inventor based in Toyama, Japan, renowned for his contributions to the field of immunology. With a remarkable portfolio of 27 patents, Takano has focused his efforts on developing innovative solutions for autoimmune diseases through the modulation of immune responses.

Latest Patents: Among his latest innovations are patents centered around immunomodulators and cell adhesion inhibitors. Notably, he has developed a method for treating autoimmune diseases that involves administering therapeutically effective amounts of a unique 4H-1-benzopyran-4-one compound. This compound boasts a complex chemical structure, defined by various substituents that allow for targeted therapeutic effects. The innovation promises significant advancements in how patients with autoimmune disorders are treated.

Career Highlights: Takano's career is highlighted by his dedication to research and development within Toyama Chemical Co., Ltd. His work has focused on the therapeutic implications of his inventions, leading to advancements in both academic and clinical settings. His patents not only provide novel methodologies for treatment but also significantly contribute to the scientific understanding of immunomodulation.

Collaborations: Throughout his career, Takano has collaborated with esteemed colleagues, including Isamu Saikawa and Kaishu Momonoi. These partnerships have fostered a synergistic approach to research, enhancing their collective ability to innovate and push the boundaries of medical science.

Conclusion: Shuntaro Takano’s impactful portfolio of patents showcases his commitment to improving healthcare outcomes for individuals suffering from autoimmune diseases. His ongoing work at Toyama Chemical Co., Ltd. ensures that his innovations in immunology continue to evolve, reflecting the dynamic nature of scientific inquiry and its application in real-world healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…